Rwanda has announced the expansion of its Human Papillomavirus (HPV) vaccination programme to include women aged between 30 and 45, as part of efforts to accelerate the elimination of cervical cancer by 2027.
The programme was announced on November 16, 2026, by the Rwanda Biomedical Centre (RBC), through its Expanded Programme on Immunization. Under the new initiative, eligible women will receive two doses of the HPV vaccine, with the second dose administered six months after the first. The expansion builds on the existing vaccination programme targeting 12-year-old girls, alongside cervical cancer screening services provided to women across the country.
ALSO READ: Bukayo Saka and Tolami Benson Spark Relationship Speculation Following Instagram Changes
Where Women Can Access the HPV Vaccine
Women aged between 30 and 45 will be able to access the HPV vaccine at health centres and other health facilities offering expanded medical services across Rwanda. The vaccine will be provided free of charge. Those seeking vaccination will be required to present a national identity card or another government-recognised document confirming their age.
ALSO READ: Rwanda National Police Hosts and Educates Solid Foundation Students
Why the Programme Is Important
Cervical cancer is largely preventable through HPV vaccination and regular screening. When detected early, it can also be treated effectively.
Despite these prevention and treatment options, cervical cancer remains the second most common cancer affecting women in Rwanda. It accounts for 13% of all cancers diagnosed in the country and is the leading cause of cancer-related deaths among women. Expanding HPV vaccination is one of the strategies aimed at reducing HPV infections and, consequently, preventing more cases of cervical cancer.
ALSO READ: NIDA to Resume e-ID Registration and Biometric Data Capture Across Rwanda
Global Goal to Eliminate Cervical Cancer
The programme aligns with the World Health Organization’s (WHO) global strategy to eliminate cervical cancer as a public health problem through the 90-70-90 targets by 2030.
The targets require countries to ensure that 90% of girls are fully vaccinated against HPV by the age of 15, 70% of women are screened using a high-performance HPV test by the ages of 35 and 45, and 90% of women identified with precancerous cervical lesions or cervical cancer receive appropriate treatment and care. These targets are intended to strengthen prevention, early detection and access to treatment, reducing the number of women affected by the disease.
ALSO READ: Mauricio Pochettino Gets Emotional as He Bids Farewell to USMNT Ahead of Manchester United Move
Women Encouraged to Access Vaccination and Screening
Expanding HPV vaccination to women aged 30 to 45 is intended to increase opportunities to prevent cervical cancer and reduce deaths associated with the disease.
Eligible women are encouraged to visit their nearest health facilities to access the free vaccine and participate in available cervical cancer screening services. Preventing cervical cancer requires sustained efforts, including vaccination, regular screening and timely treatment, to protect the health of women across the country.










































